
Dibsan 2mg/500mg/15mg Tablet SR
Marketer
Tuttsan Pharma Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dibsan 2mg/500mg/15mg Tablet SR
Glimepiride-Metformin-Pioglitazone extended-release tablets (2mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. This triple-combination therapy complements diet and exercise to enhance glycemic control. It improves insulin effectiveness, thus reducing blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Take with food to minimize gastrointestinal distress. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or missed meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal discomfort, headache, bone fractures, and respiratory infections. Prior to commencing therapy, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function assessment precedes treatment initiation. Limit alcohol consumption to mitigate the potential for increased side effects.
Uses of Dibsan 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Dibsan 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Dibsan 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Dibsan 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dibsan 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dibsan 2mg/500mg/15mg Extended-Release Tablets with a meal.
How Dibsan 2mg/500mg/15mg Tablet SR works:
Dibsan SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dibsan 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dibsan 2mg/500mg/15mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dibsan tablets (2mg/500mg/15mg) are likely unsuitable for breastfeeding mothers. Available human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Dibsan 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Dibsan 2mg/500mg/15mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should exercise caution when taking Dibsan 2mg/500mg/15mg SR tablets; dosage modification may be necessary. Consult a physician for guidance. Dibsan 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Dibsan 2mg/500mg/15mg Tablet SR :
Should you forget to take your prescribed Dibsan 2mg/500mg/15mg SR Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dibsan 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
